Ledipasvir + Sofosbuvir
Hepatitis C Virus (HCV)
ApprovedCommercial
Key Facts
About Natco Pharma
Natco Pharma Limited is a vertically integrated pharmaceutical company with a mission to improve patient access to high-quality, affordable medicines. The company has established itself as a leader in the Indian generics market, with significant achievements in developing and commercializing complex generics, including oncology drugs like lenalidomide and hepatitis C treatments. Its strategic direction focuses on expanding its branded generics portfolio, strengthening its API business, and pursuing growth in regulated markets like the US through its subsidiary Natco Pharma USA.
View full company profileTherapeutic Areas
Other Hepatitis C Virus (HCV) Drugs
| Drug | Company | Phase |
|---|---|---|
| Sofosbuvir + Velpatasvir (Hepcvir-V) | Natco Pharma | Approved |
| Bemnifosbuvir / Ruzasvir | Atea Pharmaceuticals | Phase 3 |